SCHEMBL6938529

SCHEMBL6938529

Oc1cc(-c2ccc(Cl)cc2)on1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.61
NPC1 O15118 6/20 0.56
RAB9A P51151 6/20 0.56
CDH1 P12830 1/20 0.55
CTNNB1 P35222 1/20 0.55
TCF7L2 Q9NQB0 1/20 0.55
MAPT P10636 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
HPGD P15428 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
TP53 P04637 2/20 0.48
MAPK1 P28482 1/20 0.48
RXFP1 Q9HBX9 1/20 0.46
THRB P10828 2/20 0.44
ALDH1A1 P00352 1/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375802 0.83 ALDH1A1 (0.61) NPC1RAB9AMAPTTDP1HPGD
SCHEMBL8375671 0.81 NOTUM (0.56) NOTUMNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL2959768 0.80 NPC1 (0.56) NPC1RAB9AMAPTSMN1; SMN2TDP1
SCHEMBL38657732 0.80 PTPN1 (0.61) NPC1RAB9AMAPTSMN1; SMN2L3MBTL1
SCHEMBL8377265 0.80 NPC1 (0.50) NPC1RAB9AMAPTSMN1; SMN2TDP1
SCHEMBL8380106 0.80 RAB9A (0.57) NOTUMNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL788874 0.80 ALDH1A1 (0.44) NOTUMNPC1RAB9ACDH1CTNNB1
SCHEMBL8375633 0.79 RAB9A (0.54) NPC1RAB9AMAPTSMN1; SMN2TDP1
SCHEMBL8375803 0.79 THRB (0.51) NOTUMNPC1RAB9ACDH1CTNNB1
SCHEMBL5157687 0.79 RAB9A (0.61) NOTUMNPC1RAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757042-B1 Ortho-substituted 2-methoxyiminophenylaceticacid methylester BASF AG (DE) 2003-09-10 EP disclosed
US-6605631-B1 Controlling fungi and pests; improved activity and plant tolerability BASF AKTIENGESELLSCHAFT (DE) 2003-08-12 US disclosed
US-6031110-A Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides BASF AKTIENGESELLSCHAFT (DE) 2000-02-29 US disclosed
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
CN-1216986-A Isoxazole derivatives SANKYO CO (JP) 1999-05-19 CN disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed
EP-0686152-B1 ORTHO-SUBSTITUTED 2-METHOXYIMINOPHENYLACETIC ACID METHYLAMIDES BASF AG (DE) 1997-05-02 EP disclosed
EP-0757042-A1 Ortho-substituted 2-methoxyiminophenylaceticacid methylester BASF Aktiengesellschaft (DE) 1997-02-05 EP disclosed
EP-0686152-A1 ORTHO-SUBSTITUTED 2-METHOXYIMINOPHENYLACETIC ACID METHYLAMIDES BASF AG (DE) 1995-12-13 EP disclosed
EP-0405905-B1 Use of Isoxazolin-3-one Derivatives as antidepressants SANKYO CO (JP) 1995-12-06 EP disclosed
WO-1994019331-A1 ORTHO-SUBSTITUTED 2-METHOXYIMINOPHENYLACETIC ACID METHYLAMIDES BASF AKTIENGESELLSCHAFT (DE) 1994-09-01 WO disclosed
US-5262413-A Aminoalkyloxy derivatives SANKYO COMPANY, LIMITED (JP) 1993-11-16 US disclosed
US-5217970-A Use of isoxazolin-3-one derivatives as antidepressants SANKYO COMPANY, LIMITED (JP) 1993-06-08 US disclosed
US-5116839-A Treatment of senility SANKYO COMPANY, LIMITED (JP) 1992-05-26 US disclosed
EP-0405905-A2 Use of Isoxazolin-3-one Derivatives as antidepressants Sankyo Company Limited (JP) 1991-01-02 EP disclosed